EMD-302

N/A

Report date: 2025/08/20 17:41:24

Base Information

Drug NameEMD-302
Drug Alias NameEMD-302
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionAngiopoietin like 3 modulators
TargetsAngiopoietin like 3
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmendobio Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmendobio Inc
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemiaHyperlipidemiasAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A